Treatment_types

Types of Addiction Treatment in New Jersey: A Complete Guide

By NJ Addiction Centers Editorial Team | Last reviewed: | 30 min read Clinically Reviewed

Addiction treatment is not a single intervention. It is a structured continuum of care that ranges from medically supervised detox through long-term outpatient support and recovery maintenance. The American Society of Addiction Medicine (ASAM) defines multiple levels of care, and the right placement depends on the severity of the substance use disorder, the presence of co-occurring mental health conditions, prior treatment history, and the individual’s living environment. This guide covers every major treatment modality available in New Jersey, explains how each one works, who it is designed for, and how the pieces fit together. Whether someone is evaluating options for the first time or returning to treatment after a relapse, understanding the full landscape is the first step toward an informed decision.

Key Takeaways

  • Addiction treatment follows a structured continuum from medical detox through aftercare, guided by the ASAM criteria for patient placement.
  • Inpatient (residential) rehab provides 24-hour supervised care and is recommended for severe substance use disorders or unstable living situations.
  • Outpatient programs, including IOP and PHP, allow individuals to live at home while receiving structured treatment ranging from 9 to 20+ hours per week.
  • Medical detox is the clinical management of withdrawal and is often the first step before entering a treatment program, not a standalone solution.
  • Medication-assisted treatment (MAT) combines FDA-approved medications like buprenorphine, methadone, or naltrexone with behavioral therapy to treat opioid and alcohol use disorders.
  • Evidence-based therapies such as CBT, DBT, and EMDR are core components of most treatment programs and address the psychological drivers of addiction.
  • Dual diagnosis treatment integrates care for addiction and co-occurring mental health disorders, which SAMHSA estimates affect roughly half of those with a substance use disorder.
  • New Jersey operates a partial care system and licenses treatment facilities through the Division of Mental Health and Addiction Services (DMHAS).

How Addiction Treatment Works: Levels of Care

Addiction treatment is organized around a clinical framework called the ASAM criteria, developed by the American Society of Addiction Medicine. Rather than prescribing a fixed program for everyone, the ASAM criteria use a multidimensional assessment to match individuals to the appropriate level of care based on six dimensions: acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse or continued use potential, and recovery environment.

ASAM Levels of Care: The ASAM continuum defines treatment intensity on a scale from 0.5 (early intervention) through Level 4 (medically managed intensive inpatient). The most commonly referenced levels in addiction treatment are:

  • Level 1 — Outpatient Services: Fewer than 9 hours of treatment per week, suitable for individuals with mild substance use disorders and a stable living environment.
  • Level 2.1 — Intensive Outpatient (IOP): Typically 9 to 19 hours per week, structured around group and individual therapy while the individual lives at home.
  • Level 2.5 — Partial Hospitalization (PHP): 20 or more hours per week of clinically intensive programming, often used as a step-down from residential care or a step-up from IOP.
  • Level 3.1 through 3.7 — Residential/Inpatient: 24-hour care in a structured setting, ranging from clinically managed low-intensity residential to medically monitored intensive inpatient.
  • Level 4 — Medically Managed Intensive Inpatient: Hospital-based care for patients with severe medical or psychiatric needs during treatment.

In New Jersey, treatment facilities are licensed through the Division of Mental Health and Addiction Services (DMHAS), a division within the NJ Department of Human Services. DMHAS sets licensing standards for all substance use disorder treatment providers in the state, and facilities must meet these standards to operate legally. Many NJ programs also seek national accreditation through CARF (Commission on Accreditation of Rehabilitation Facilities) or the Joint Commission (JCAHO), which indicates adherence to additional quality benchmarks.

Understanding these levels matters because treatment is not one-size-fits-all. A person with a severe opioid use disorder, unstable housing, and untreated depression will need a very different treatment plan than someone with a mild alcohol use disorder and a supportive home environment. The ASAM criteria provide the clinical logic for those decisions.

For a detailed comparison of how inpatient and outpatient settings differ in practice, see our guide to inpatient vs. outpatient rehab.

Inpatient and Residential Treatment

Inpatient rehab, also called residential treatment, provides 24-hour care in a supervised facility. Residents live on-site for the duration of the program and follow a structured daily schedule that typically includes individual therapy, group counseling, psychoeducation, and, when appropriate, medication management. Programs generally run 30, 60, or 90 days, though the clinically appropriate duration varies based on the individual’s assessment.

Residential treatment corresponds to ASAM Levels 3.1 through 3.7. The lower end of that range involves clinically managed low-intensity residential services (often called halfway houses or therapeutic communities), while the higher end involves medically monitored settings with on-site nursing and physician oversight.

Who inpatient treatment is designed for: ASAM criteria recommend residential care for individuals who meet one or more of the following conditions: severe substance use disorder that has not responded to outpatient treatment, co-occurring mental health conditions that require stabilization in a structured environment, an unstable or unsafe living situation, or a history of relapse during less intensive treatment. Inpatient is not automatically “better” than outpatient. It is more intensive and more restrictive, which is clinically appropriate for some people and unnecessary for others.

What a typical day looks like: Most residential programs structure the day around therapy blocks. A common schedule includes morning group therapy, an individual session with a counselor or therapist, afternoon psychoeducation or skills training, and evening peer support meetings such as 12-step or SMART Recovery groups. Facilities may also offer experiential therapies like art therapy, exercise programming, or mindfulness sessions.

New Jersey has a range of residential treatment facilities, from state-funded programs that accept Medicaid to private programs that accept commercial insurance or self-pay. The NJ Division of Mental Health and Addiction Services maintains a directory of licensed residential providers.

For individuals who need longer stays, programs extending to 90 or 120 days provide additional time for stabilization and skill-building. Research supported by the National Institute on Drug Abuse (NIDA) indicates that treatment lasting at least 90 days is associated with better outcomes for individuals with severe substance use disorders, though this does not mean shorter programs are ineffective for those with less severe presentations.

For a deeper look at how residential treatment works, read our guide to inpatient rehab. For information on extended programs, see long-term residential rehab.

Outpatient Programs: IOP, PHP, and Standard Outpatient

Outpatient treatment allows individuals to live at home, or in a sober living residence, while attending structured treatment sessions during the day or evening. The term “outpatient” covers a range of intensity levels, from a few hours per week to near-full-day programming.

Standard Outpatient (ASAM Level 1)

Standard outpatient care involves fewer than 9 hours of structured programming per week. It typically includes one to two individual therapy sessions and one to two group sessions. Standard outpatient is most appropriate for individuals with mild substance use disorders, those who have completed a higher level of care and are stepping down, or individuals whose work and family responsibilities require maximum scheduling flexibility.

Intensive Outpatient Programs (IOP) — ASAM Level 2.1

Intensive Outpatient Program (IOP): A structured treatment program providing 9 to 19 hours of clinical services per week, typically delivered over 3 to 5 days. IOP programs focus on group therapy, individual counseling, relapse prevention skills, and, in many cases, family therapy components.

IOPs are one of the most commonly utilized treatment levels in New Jersey. They serve as both a primary treatment option for individuals with moderate substance use disorders and a step-down from residential or PHP care. Many NJ IOPs offer both daytime and evening scheduling, making them accessible to individuals who work or attend school.

For a full breakdown of what IOP involves, see our guide to intensive outpatient programs.

Partial Hospitalization Programs (PHP) — ASAM Level 2.5

Partial Hospitalization Program (PHP): A clinically intensive outpatient program providing 20 or more hours of treatment per week, typically 5 to 6 days per week. PHP programs offer a level of clinical intensity close to inpatient care but allow the individual to return home or to a sober living residence in the evening.

In New Jersey, partial hospitalization is sometimes referred to within the broader “partial care” system, which is a state-specific designation for intensive day programming that may include both substance use disorder and mental health treatment. NJ partial care programs are licensed by DMHAS and may be operated by hospitals, community mental health centers, or standalone treatment providers.

PHP is most appropriate for individuals who need more structure than IOP provides but do not require 24-hour residential supervision. It is frequently used as a step-down from inpatient treatment or as an initial placement for individuals whose clinical assessment indicates a need for intensive daily programming without overnight care.

For more detail, read our guide to partial hospitalization programs.

Choosing Between Outpatient Levels

The clinical difference between IOP and PHP is primarily one of hours and intensity. The decision between them is driven by the ASAM assessment, not personal preference. A clinical professional evaluates the six ASAM dimensions and recommends the level that matches the individual’s current needs. Insurance authorization also plays a role, as most payers require clinical justification for PHP-level care.

For a side-by-side comparison, see our guide to outpatient rehab programs. For information on how insurance covers these programs, visit our insurance and cost guide.

Medical Detox and Withdrawal Management

Medical detoxification is the clinical management of acute withdrawal symptoms that occur when a person stops using a substance after a period of physical dependence. Detox is a medical process, not a treatment program. It addresses the physiological effects of withdrawal and stabilizes the patient so they can safely enter a treatment program.

Medical Detox: A supervised process in which physicians and nurses monitor vital signs, manage withdrawal symptoms with medications when indicated, and ensure patient safety during the acute withdrawal period. Detox typically takes place in a hospital, a dedicated detox facility, or the medical unit of a residential treatment center.

The duration and severity of withdrawal depend heavily on the substance. Alcohol withdrawal can begin within 6 to 12 hours of the last drink and, in severe cases, can cause life-threatening seizures or delirium tremens. Opioid withdrawal is intensely uncomfortable but generally not fatal in otherwise healthy adults. Benzodiazepine withdrawal, like alcohol withdrawal, carries a risk of seizures and requires careful medical tapering. Stimulant withdrawal (cocaine, methamphetamine) is primarily psychological rather than physiological but can involve severe depression and fatigue.

Substance-Specific Detox Protocols

  • Alcohol detox typically involves benzodiazepine tapering protocols under medical supervision, with monitoring for complications such as seizures or Wernicke-Korsakoff syndrome. For a detailed timeline and what to expect, see our guide to alcohol detox.
  • Opioid detox may involve the use of buprenorphine (Suboxone), methadone, or clonidine to manage withdrawal symptoms. Many detox programs initiate medication-assisted treatment during the detox phase. For more on protocols and medications, see our guide to opioid detox.
  • Benzodiazepine detox requires a slow, medically supervised taper — abrupt cessation can be dangerous. This process may take weeks or months depending on the duration and dosage of use.

Medical Detox vs. Social Detox

Not all detox programs provide the same level of medical oversight. Medical detox involves physician-directed care with medication management and continuous monitoring. Social detox, also called non-medical detox, provides a supportive environment and peer support but does not include medical interventions. For substances with potentially dangerous withdrawal syndromes (alcohol, benzodiazepines), medical detox is the clinically appropriate choice. For a comparison of these approaches, see our guide to medical detox vs. social detox.

A critical point that is often misunderstood: completing detox is not completing treatment. Detox manages the acute physical withdrawal phase, but it does not address the behavioral, psychological, and social factors that drive substance use disorders. NIDA’s Principles of Drug Addiction Treatment state that detoxification alone, without subsequent treatment, does little to change long-term drug use. Detox is a clinically necessary first step for many people, but it should be followed by a structured treatment program.

New Jersey has both hospital-based and standalone detox facilities. Many residential treatment centers in the state include a detox phase at the beginning of the program, allowing for a seamless transition from withdrawal management into active treatment.

For a comprehensive overview, read our guide to medical detox.

Evidence-Based Therapies Used in Treatment

The therapeutic component of addiction treatment is where behavioral change happens. While detox addresses physical dependence and the treatment setting provides structure, it is the therapy modalities used within those settings that address the underlying patterns of thought, emotion, and behavior that sustain substance use disorders. Most accredited treatment programs in New Jersey use a combination of the following evidence-based approaches.

Cognitive Behavioral Therapy (CBT)

Cognitive Behavioral Therapy (CBT): A structured, goal-oriented therapy that helps individuals identify and change the thought patterns and beliefs that contribute to substance use. CBT teaches coping skills for managing cravings, avoiding triggers, and responding to high-risk situations without using substances.

CBT is one of the most extensively researched therapies in addiction treatment. It is used across all levels of care, from outpatient to residential, and is effective for a wide range of substance use disorders. CBT is often delivered in both individual and group formats.

Dialectical Behavior Therapy (DBT)

Dialectical Behavior Therapy (DBT): Originally developed for borderline personality disorder, DBT has been adapted for substance use disorders, particularly in individuals who experience intense emotional dysregulation. DBT combines cognitive behavioral techniques with mindfulness and distress tolerance skills. It emphasizes balancing acceptance and change.

DBT is especially relevant in dual diagnosis treatment, where addiction co-occurs with mood disorders, personality disorders, or trauma-related conditions. For a full guide to how DBT is used in addiction treatment, see DBT therapy. For a comparison of the two most common talk therapy modalities, see DBT vs. CBT.

Eye Movement Desensitization and Reprocessing (EMDR)

EMDR Therapy: A trauma-focused therapy that uses bilateral stimulation (typically guided eye movements) to help individuals process and reframe traumatic memories. EMDR is used in addiction treatment because trauma and substance use disorders frequently co-occur. Unresolved trauma is a well-documented driver of substance use as a coping mechanism.

EMDR has been endorsed by the World Health Organization (WHO) and the U.S. Department of Veterans Affairs as an effective treatment for post-traumatic stress disorder (PTSD). Its application in addiction treatment is growing, particularly in programs that treat co-occurring PTSD and substance use disorders. For more detail, see our guide to EMDR therapy, and for a comparison of trauma-focused approaches, see EMDR vs. somatic therapy vs. art therapy.

Motivational Interviewing (MI)

Motivational Interviewing (MI): A collaborative, person-centered counseling approach that helps individuals resolve ambivalence about changing their substance use behavior. MI does not confront or persuade. Instead, it draws out the individual’s own motivations for change by exploring their values, goals, and the discrepancy between their current behavior and where they want to be.

MI is frequently used in early treatment engagement, when individuals may be uncertain about committing to a full course of treatment. It is also used throughout the treatment process to sustain motivation during difficult phases.

Contingency Management

Contingency Management (CM): A behavioral therapy that uses tangible rewards (such as vouchers or privileges) to reinforce positive behaviors like maintaining abstinence, attending therapy sessions, or completing treatment milestones. CM has strong research support, particularly for stimulant use disorders where pharmacological treatments are limited.

These therapies are not mutually exclusive. Most treatment programs use a combination of modalities tailored to the individual’s needs, informed by their clinical assessment and treatment plan.

Medication-Assisted Treatment (MAT)

Medication-Assisted Treatment (MAT): The use of FDA-approved medications in combination with behavioral therapy and counseling to treat substance use disorders. MAT is the clinical standard of care for opioid use disorder and is also used in the treatment of alcohol use disorder.

MAT is not “replacing one drug with another,” a persistent misconception that SAMHSA and NIDA have directly addressed. The medications used in MAT are clinically prescribed, taken at stable therapeutic doses, and work by reducing cravings, blocking the euphoric effects of opioids, or managing withdrawal symptoms, allowing the individual to engage in the behavioral work of recovery.

FDA-Approved Medications for Opioid Use Disorder

  • Buprenorphine (Suboxone, Sublocade): A partial opioid agonist that reduces cravings and withdrawal symptoms without producing the full euphoric effect of opioids. Buprenorphine can be prescribed in office-based settings by qualified providers. The SUPPORT Act of 2018 and subsequent federal policy changes have expanded prescribing access.
  • Methadone: A full opioid agonist administered through certified Opioid Treatment Programs (OTPs). Methadone is dispensed daily in a clinical setting and is effective for individuals with severe opioid use disorder. New Jersey has multiple OTPs across the state.
  • Naltrexone (Vivitrol): An opioid antagonist that blocks the effects of opioids. Vivitrol is administered as a monthly injection, which removes the daily adherence challenge. Naltrexone requires full detox from opioids before initiation, which can be a barrier for some patients.

FDA-Approved Medications for Alcohol Use Disorder

  • Naltrexone: Also used for alcohol use disorder, naltrexone reduces the rewarding effects of alcohol. Available in both oral (daily tablet) and injectable (Vivitrol) forms.
  • Acamprosate (Campral): Helps stabilize brain chemistry disrupted by chronic alcohol use and reduces post-acute withdrawal symptoms like anxiety, insomnia, and restlessness.
  • Disulfiram (Antabuse): Creates an aversive physical reaction (nausea, flushing) when alcohol is consumed, serving as a deterrent. Less commonly used today than naltrexone or acamprosate.

New Jersey has expanded MAT access significantly in recent years. The NJ Department of Human Services has funded initiatives to integrate MAT into primary care settings, emergency departments, and county jail systems. According to SAMHSA, New Jersey has over 100 providers authorized to prescribe buprenorphine, and the state operates multiple certified OTPs for methadone dispensing.

MAT is most effective when combined with counseling and behavioral therapy. Medication alone addresses the neurological component of addiction, but the behavioral therapies described in the previous section address the psychological and social components. Integrated MAT programs that combine both have the strongest evidence base.

For a complete guide to how MAT works, available medications, and access in New Jersey, see our dedicated page on medication-assisted treatment.

Specialized and Alternative Treatment Approaches

Beyond the core levels of care and evidence-based therapies, the addiction treatment landscape includes several specialized and alternative approaches. These programs may be integrated into traditional treatment settings or offered as standalone options.

12-Step Programs

12-Step Program: A peer-support recovery framework based on the principles originally developed by Alcoholics Anonymous (AA). The 12 steps involve a structured process of acknowledging powerlessness over addiction, engaging in self-examination, making amends, and committing to ongoing personal development and service to others.

12-step programs are not clinical treatment. They are mutual-aid groups that many treatment programs incorporate as a complement to professional therapy. The 12-step model remains the most widely available peer recovery resource in the United States, with AA and Narcotics Anonymous (NA) meetings held in communities throughout New Jersey.

Research on 12-step effectiveness is mixed but substantial. A Cochrane review found that AA and 12-step facilitation therapies were as effective as other established treatments for increasing abstinence. However, the spiritual framework of 12-step programs is not a fit for everyone, and alternative mutual-aid approaches exist.

For a detailed look at how 12-step programs work, see our guide to the 12-step program.

SMART Recovery and Non-12-Step Approaches

SMART Recovery: A science-based mutual-aid program that uses cognitive behavioral and motivational enhancement techniques. Unlike 12-step programs, SMART Recovery does not use a spiritual framework and emphasizes self-empowerment rather than the concept of powerlessness.

SMART Recovery meetings are available in New Jersey, though less widely than AA or NA. Some treatment programs offer both 12-step facilitation and SMART Recovery groups, allowing individuals to choose the approach that resonates with them. For a comparison, see 12-step vs. SMART Recovery vs. harm reduction.

Faith-Based Rehab Programs

Faith-based rehabilitation programs integrate religious or spiritual principles into the recovery process. These programs may be affiliated with a specific denomination or broadly spiritual. Some faith-based programs are clinically licensed and use evidence-based therapies alongside spiritual components, while others rely primarily on pastoral counseling and spiritual practice.

An important distinction: clinically licensed faith-based programs must meet the same state licensing standards as secular programs. Not all faith-based programs hold clinical licenses, which may affect insurance coverage and the availability of medical services. For more detail, see our guide to faith-based rehab programs.

Holistic and Alternative Therapies

Holistic approaches to addiction treatment incorporate practices such as mindfulness meditation, yoga, acupuncture, equine therapy, and nutritional counseling alongside traditional clinical treatment. These modalities are generally used as complementary therapies rather than replacements for evidence-based treatment.

The evidence base for holistic approaches varies. Mindfulness-based relapse prevention has a growing body of research supporting its effectiveness as an adjunct to standard treatment. Yoga and exercise programming have been associated with reduced stress and improved mood during recovery. Other modalities, such as equine therapy and acupuncture, have less robust evidence but are offered by many programs based on clinical experience and patient preference.

For a review of holistic approaches, see our guide to holistic and alternative addiction therapies.

Luxury and Executive Rehab Programs

Luxury and executive rehab programs offer residential treatment with enhanced amenities, private accommodations, and services designed for professionals who need to maintain some level of work connectivity during treatment. These programs typically accept self-pay or high-end commercial insurance and are priced significantly above standard residential treatment.

The clinical programming in a quality luxury or executive program should meet the same evidence-based standards as any accredited residential facility. The premium is for the environment and amenities, not for a different clinical model. For more information, see luxury and executive rehab programs.

Rehab for Veterans

Veterans face unique challenges related to addiction, including high rates of co-occurring PTSD, traumatic brain injury (TBI), and military sexual trauma (MST). The U.S. Department of Veterans Affairs (VA) offers specialized substance use disorder treatment programs, and some private treatment centers have developed veteran-specific tracks that incorporate trauma-informed care, peer support from other veterans, and coordination with VA benefits.

In New Jersey, veterans can access addiction treatment through the VA New Jersey Health Care System or through community-based providers that accept TRICARE or VA Community Care referrals. For a full guide to veteran-specific treatment options, see rehab for veterans.

The Evidence Ranking: Which Treatment Works Best for Which Substance

Treatment modalities are not interchangeable. The evidence base favors specific combinations for specific substance use disorders, and those combinations differ substantially — in effect size, in the level of clinical support, and in what counts as first-line treatment. Generic “all modalities help” framing is accurate but not useful for decision-making. Below is the evidence-grounded ranking, organized by substance.

Opioid Use Disorder — medication-first is unambiguous. The three FDA-approved medications (buprenorphine, methadone, extended-release naltrexone) have the strongest evidence base of any addiction treatment intervention. A Cochrane review covering 31 trials found methadone maintenance retains patients in treatment at roughly 4.4× the rate of non-pharmacological approaches, and multiple meta-analyses show MAT reduces mortality by 50%+ compared to behavioral treatment alone. NIDA, SAMHSA, ASAM, and the Surgeon General have each issued guidance that MAT is the first-line treatment for OUD. Behavioral treatment (CBT, contingency management, 12-step facilitation) is additive to MAT, not a substitute. A program that offers OUD treatment without MAT, or pressures patients toward abstinence-only models, is operating outside the current standard of care.

Alcohol Use Disorder — medications are under-used despite strong evidence. Three FDA-approved medications exist for AUD: naltrexone (oral or extended-release injection Vivitrol), acamprosate (Campral), and disulfiram (Antabuse). NIAAA’s COMBINE study and subsequent research show naltrexone meaningfully reduces heavy drinking days; acamprosate supports abstinence maintenance particularly post-detox. Medications are prescribed to only a small minority of patients with AUD despite evidence supporting broader use. Behavioral treatment evidence ranking: Cognitive Behavioral Therapy (CBT) has the largest evidence base, followed by Motivational Enhancement Therapy (MET) and 12-step facilitation. A combination of medication + behavioral treatment + mutual aid produces the strongest outcomes.

Stimulant Use Disorder — behavioral is all we have, but contingency management is under-prescribed. No FDA-approved medications exist for cocaine or methamphetamine use disorder. Within behavioral treatments, contingency management (CM) has the strongest evidence by a wide margin — providing tangible incentives (vouchers, prizes, privileges) for negative drug screens reduces stimulant use more effectively than any other intervention. NIDA has repeatedly called for broader adoption. CM is under-used because reimbursement structures haven’t historically supported it, though that is changing. CBT and Matrix Model (a structured 16-week outpatient program) are second-line. A program that treats stimulant use disorder primarily with 12-step facilitation and traditional therapy is providing below-evidence-level care.

Cannabis Use Disorder — smaller evidence base, CBT/MET lead. No FDA-approved medications. CBT and Motivational Enhancement Therapy have the most evidence, though the overall evidence base is smaller than for other SUDs. Length of treatment matters more than modality specifics; extended programs produce better outcomes than brief interventions.

Benzodiazepine Dependence — slow tapering, not rapid detox. The evidence base favors gradual dose reduction over weeks to months (often following the Ashton Manual protocol or comparable). Rapid detox produces severe, sometimes protracted, withdrawal syndromes and is associated with relapse. Flumazenil protocols (used by some rapid-detox programs) are not supported by strong evidence and carry seizure risk. Behavioral support during tapering — particularly CBT for anxiety, which often underlies benzodiazepine use — is clinically important. Sudden discontinuation can be fatal.

Co-occurring SUD + Mental Health — integrated care, not sequential. Research consistently shows that integrated treatment of both conditions simultaneously produces better outcomes than treating SUD first and mental health second (or vice versa). Specific modalities: Seeking Safety has strong evidence for SUD + PTSD. Dialectical Behavior Therapy (DBT) has strong evidence for SUD + borderline personality disorder and SUD + emotion dysregulation. Trauma-Focused CBT (TF-CBT) for SUD + complex trauma. A program that treats co-occurring conditions in parallel silos (“we handle the addiction, psychiatry handles the mood disorder”) is clinically inferior to programs with integrated clinical teams.

Modalities that sound clinical but have limited evidence. Equine therapy, art therapy, wilderness therapy, and adventure-based programs have some supportive anecdotal data but limited rigorous trial evidence for addiction-specific outcomes. These can be meaningful adjuncts to evidence-based core treatment but should not be the primary therapeutic intervention. If a program presents them as primary, that is a signal to look elsewhere.

Modalities that sound unusual but have strong evidence. Contingency management (already discussed) — the “giving patients rewards for clean urines” model sounds like it shouldn’t work but has among the strongest evidence in the entire addiction treatment literature. Mindfulness-Based Relapse Prevention (MBRP) has growing evidence for relapse prevention across substances. Community Reinforcement Approach (CRA) and CRAFT (for families) have strong evidence despite limited market penetration.

The clinical bottom line. For a given substance + co-occurring profile, ask the admissions team directly: “Which modality has the strongest evidence for my situation, and does your program provide it?” A program that can answer specifically — “for opioid use disorder we do buprenorphine with weekly individual CBT and peer support” — is more likely to deliver evidence-based care than one that lists a generic menu of modalities.

Stepping Up and Stepping Down: Level-of-Care Transitions

Treatment is rarely a single level of care. Most effective treatment episodes involve transitions — from detox to residential to PHP to IOP to outpatient, with some variation depending on severity and response. These transitions are clinical decisions driven by specific criteria, not calendar dates. Understanding what triggers a step-up or step-down clarifies what to expect and what to ask about during treatment.

Step-down criteria — moving to a less intensive level. The ASAM criteria define readiness across the same six dimensions used for initial placement. Specific indicators that a step-down is appropriate:

  • Withdrawal symptoms have resolved or are managed without 24-hour medical monitoring
  • Acute mental health symptoms (suicidal ideation, severe depression, psychosis) have stabilized
  • The patient demonstrates adequate engagement with treatment — attending groups, participating in therapy, using coping skills
  • A stable living environment is available or has been arranged
  • The patient has the cognitive and motivational resources to maintain progress at a lower intensity
  • Any medical conditions requiring 24-hour monitoring have resolved or are managed with outpatient follow-up

Step-up criteria — moving to a more intensive level. Less common but clinically important when it occurs:

  • Resumption of substance use despite current level of care
  • Escalation of co-occurring mental health symptoms
  • Withdrawal symptoms emerging that were not anticipated (common in delayed-onset cases)
  • Home environment becoming unstable or unsafe
  • The patient explicitly requesting more structure (this is a valid clinical signal, not “weakness”)

Typical treatment-episode progression by severity.

  • Mild SUD with stable life context — Level 1 outpatient for 3-6 months, potentially stepping up if plateauing. MAT if indicated (OUD, AUD).
  • Moderate SUD with minor instability — IOP for 8-12 weeks, stepping down to Level 1 outpatient for maintenance. Dual diagnosis treatment if co-occurring mental health.
  • Severe SUD without medical complications — PHP or residential 30 days, IOP 8 weeks, Level 1 outpatient ongoing. MAT for OUD/AUD.
  • Severe SUD with medical complications (seizure-risk withdrawal, severe mental health, polysubstance) — Medical detox 3-10 days, residential 30-60+ days, PHP or IOP step-down, Level 1 outpatient long-term. MAT, integrated co-occurring treatment.

These are clinical patterns, not prescriptions. Individual cases vary based on the six ASAM dimensions.

Who makes the transition decision. In NJ, level-of-care transitions are typically decided by the treatment team — the clinical director, primary counselor, and medical director, with input from the patient. Insurance utilization review also plays a role; an insurer may determine the patient no longer meets medical necessity for the current level and authorize only the next step down. Patients have the right to participate in treatment planning decisions and the right to appeal insurer determinations (covered on the insurance and cost page).

Common mistakes in transition decisions.

  1. Stepping down too fast because insurance authorized fewer days. Clinical readiness and insurance authorization are not the same thing. If the treatment team believes continued residential care is clinically necessary and the insurer authorizes step-down to IOP, an appeal is warranted.
  2. Stepping down too slowly because the patient “seems comfortable.” Prolonged residential care past the point of clinical necessity can foster institutional dependence and delay the skill-building that happens when a patient engages with real-world triggers in a structured outpatient setting.
  3. Treating each step as an endpoint. Residential discharge is not the goal; sustained recovery is. A patient who views residential as “the end of treatment” and discontinues follow-up in outpatient has a high relapse risk regardless of how successful the residential episode was.
  4. Skipping steps in the continuum. Discharging directly from residential to standard outpatient without an intermediate IOP or PHP level is associated with worse outcomes than stepping through the full continuum. The stepping-down process itself has therapeutic value — it allows graduated exposure to real-world stressors with progressively less clinical support.

The post-discharge handoff. Transitions are highest-risk when the handoff is imperfect — the residential program didn’t coordinate with the outpatient program, the first IOP appointment is scheduled 10 days after discharge instead of 3 days, or no medication refill was arranged for MAT continuity. Pressing for specific handoff details during discharge planning — who the new provider is, what the first-appointment date is, who has which records, how MAT continuity is ensured — is one of the most underrated treatment-advocacy moves a patient or family member can make.

Dual Diagnosis and Co-Occurring Disorder Treatment

Dual Diagnosis: A clinical term used when an individual is diagnosed with both a substance use disorder and a co-occurring mental health disorder, such as depression, anxiety, PTSD, bipolar disorder, or a personality disorder.

Co-occurring disorders are not the exception in addiction treatment. They are the norm. According to SAMHSA’s National Survey on Drug Use and Health, approximately half of individuals with a substance use disorder also meet criteria for a mental health disorder. The relationship between the two is bidirectional: mental health conditions can drive substance use as a coping mechanism, and chronic substance use can trigger or worsen psychiatric symptoms.

Why Integrated Treatment Matters

Historically, substance use disorders and mental health disorders were treated separately, often by different providers in different systems. A person might complete addiction treatment, only to relapse because their underlying depression or PTSD was never addressed. Or they might receive psychiatric treatment that stabilized their mood but did not address the addiction.

Integrated dual diagnosis treatment addresses both conditions simultaneously within the same program. This means the treatment team includes both addiction counselors and mental health professionals (psychiatrists, psychologists, or licensed clinical social workers), and the treatment plan is coordinated to address the interaction between the two conditions.

What Integrated Treatment Looks Like

A dual diagnosis program typically includes psychiatric evaluation and medication management for the mental health condition, evidence-based addiction therapies (CBT, DBT, MI), trauma-specific therapies (EMDR, prolonged exposure) when indicated, and ongoing monitoring for how each condition affects the other. The ASAM criteria include a specific dimension for emotional, behavioral, and cognitive conditions, which means that the presence of a co-occurring mental health disorder influences the recommended level of care.

In New Jersey, many residential and outpatient treatment programs are licensed to provide dual diagnosis services. However, the depth of psychiatric integration varies significantly between programs. When evaluating a program for dual diagnosis treatment, key questions include whether the program has a psychiatrist on staff (not just available by referral), whether mental health treatment is integrated into the daily schedule or handled separately, and whether the program uses evidence-based therapies for both conditions.

For a comprehensive overview of dual diagnosis treatment, see our dedicated guide to dual diagnosis treatment. For a list of evaluated programs in the state, see best dual diagnosis treatment centers in New Jersey.

Understanding dual diagnosis is also closely connected to choosing the right rehab program, since the presence of co-occurring disorders is one of the most important factors in treatment selection. After completing treatment, continued mental health care is a core part of recovery and aftercare planning.

Topics in This Guide

This pillar page provides an overview of every major addiction treatment type available in New Jersey. Each section links to a dedicated, in-depth guide. Use the links below to navigate directly to the topic you are looking for.

Levels of Care and Settings

Detox and Withdrawal Management

Evidence-Based Therapies

Medication-Assisted Treatment

Specialized Approaches

Co-Occurring Disorders

Related Guides

This guide is part of NJ Addiction Centers — New Jersey’s independent addiction treatment resource. Content is reviewed quarterly and updated to reflect current clinical standards and New Jersey regulatory requirements. This site is an informational resource and is not a treatment provider.

Looking for treatment options in your area? We can help point you in the right direction. (888) 699-0742 — or request a callback.